epithalon oral vs subcutaneous bioavailability Benefits and Research Applications Epithalon - Peptide for Aging

Two studies used primarily fulguration

2022 May 9;13:754165

This HTS protocol seems biased to detect compounds targeting aggregated structures rather than monomeric proteins, which represents a clear advantage for its potential therapeutic use since they would only target pathological -Syn assemblies without interfering with the activity of the soluble and functional protein

GHK-Cu is the better call when skin needs repair, recovery, or can't tolerate retinoid irritation

NO system dependence of atropine-induced mydriasis and L-NAME and L-arginine-induced miosis: Reversal by the pentadecapeptide BPC 157 in rats and guinea pigs